If you have trouble reading this email click here.
Download 0509_BioTek_Stimulus_Funding.doc (172 KB)

May 13, 2009, WINOOSKI VT, USA — The 2009 U.S. American Recovery and Reinvestment Act (ARRA) provides funds including $10.4 billion for the National Institutes of Health (NIH); the majority of which is to be used for research-directed awards. This unprecedented stimulus package provides Government funded grant money to life science researchers for investment in facilities and equipment. To assist you with obtaining NIH Stimulus Grant funds, BioTek Instruments, Inc. has created the NIH Stimulus Grant Resources page on its website, a one-stop collection of information regarding Grants, Articles and associated links for U.S. Recovery Act opportunities in the life science research field.
Your local BioTek sales representative can help to sort through the many ARRA options by discussing your Microplate Instrumentation needs and presenting you with the best options and the right solutions for your situation. BioTek's complete line of microplate-based instrumentation affords researchers the latest in microplate technologies. For those who are currently not using microplate technology, a BioTek sales representative can introduce the benefits of this format including a reduction in sample and reagent costs, with sample sizes as low as 1µL, as well as increased sample throughput.
BioTek's full line of microplate instrumentation solutions are designed, assembled and quality tested in the U.S.A., and are available on GSA Contract, including:
Our company-wide commitment to quality and value means your assays will be rapid, efficient and successful. Contact your local BioTek sales representative about your Stimulus Grant opportunity and Microplate Instrumentation needs, and we will be happy to help you Get a Better Reaction.
BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to facilitate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research.
For further information, contact:
Chere Griffin, Account Executive
Shaw & Todd Advertising and Marketing Communications###
Downloads are located at top of page.